United-Guardian, Inc.

UG Consumer Defensive Household & Personal Products

United-Guardian, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.5 million, down 13.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.52%, EPS grew 14.3% and free cash flow grew 428.4%, each against the same quarter a year earlier.

6.90 0.10 −1.43%
Market cap
$31.7M
P/E
12.8×
Fwd P/E
18.7×
Dividend yield
7.97%
F-score
5/9
Altman Z
12.53
Beneish M
−2.64
Dividend safety
20/100

United-Guardian, Inc. (UG) Business Profile

Updated before January 2025

Company Overview

United-Guardian, Inc. (UG) is a publicly traded company specializing in the development, manufacturing, and marketing of high-quality personal care, healthcare, and industrial products. Founded in 1942, UG has built a reputation for innovation and reliability in its niche markets. The company is headquartered in Hauppauge, New York, and operates with a lean but highly skilled workforce. UG’s leadership team is spearheaded by its CEO, Ken Globus, who has been instrumental in driving the company’s growth and maintaining its focus on research and development. Over the years, UG has established itself as a trusted partner for businesses across various industries, leveraging its expertise in specialty chemicals and unique formulations.

Core Business Segments

United-Guardian operates in three primary business segments:

1. Personal Care Products

UG is well-known for its proprietary personal care products, which include a range of skincare and haircare formulations. The company’s flagship product in this category is Lubrajel®, a water-based moisturizing and lubricating gel widely used in cosmetics and personal care products. Lubrajel® is available in various formulations tailored to meet the needs of different skin types and applications. Other offerings in this segment include specialty ingredients for anti-aging products, sunscreens, and hair conditioners.

2. Healthcare Products

UG also has a strong presence in the healthcare sector, providing products that cater to both medical and pharmaceutical applications. The company’s medical-grade Lubrajel® formulations are used as lubricants in medical devices and as moisturizers in wound care products. Additionally, UG supplies specialty ingredients for oral care products, including dental gels and mouthwashes.

3. Industrial Products

In the industrial sector, UG offers specialty chemicals used in a variety of applications, such as lubricants for machinery and specialty coatings. These products are designed to meet the stringent requirements of industrial clients, ensuring high performance and reliability.

Business Model

United-Guardian’s business model is centered around innovation, quality, and long-term partnerships. The company invests heavily in research and development to create unique, high-value products that address specific market needs. UG generates revenue through direct sales to manufacturers and distributors, as well as through licensing agreements with other companies. By focusing on niche markets, UG has been able to maintain strong profit margins and a loyal customer base. The company’s lean operational structure and focus on high-margin products contribute to its financial stability and growth.

Strategic Direction

United-Guardian is committed to expanding its product portfolio and entering new markets. The company is actively exploring opportunities in the natural and sustainable product segments, reflecting growing consumer demand for eco-friendly solutions. UG is also focused on enhancing its global distribution network to reach new customers in emerging markets. In addition, the company plans to invest in advanced manufacturing technologies to improve efficiency and reduce its environmental footprint. By aligning its strategic goals with market trends, UG aims to sustain its growth and remain competitive in the long term.

Competitive Landscape

United-Guardian operates in highly competitive markets, facing competition from both large multinational corporations and smaller specialty chemical companies. Key competitors in the personal care segment include BASF, Dow Chemical, and Croda International, all of which offer a wide range of cosmetic ingredients. In the healthcare sector, UG competes with companies like Lubrizol and Ashland, which also provide specialty chemicals for medical and pharmaceutical applications. Despite the competition, UG differentiates itself through its focus on niche markets, proprietary formulations, and strong customer relationships.

Risk Factors

Like any business, United-Guardian faces several risks that could impact its operations and financial performance. These include:

  • Market Dependence: UG relies heavily on the success of its flagship products, such as Lubrajel®. A decline in demand for these products could significantly affect the company’s revenue.
  • Supply Chain Disruptions: The company sources raw materials from various suppliers. Any disruption in the supply chain, whether due to geopolitical issues, natural disasters, or other factors, could impact production.
  • Regulatory Risks: As a manufacturer of personal care and healthcare products, UG must comply with stringent regulations. Changes in regulatory requirements could increase costs or limit market access.
  • Economic Conditions: The company’s performance is influenced by global economic conditions, which can affect consumer spending and industrial activity.

Recent Developments

In recent years, United-Guardian has introduced new formulations of its Lubrajel® product line to meet the evolving needs of its customers. The company has also expanded its distribution network in Asia and Europe, capitalizing on growing demand in these regions. Additionally, UG has invested in sustainability initiatives, such as developing biodegradable and eco-friendly product formulations. The COVID-19 pandemic posed challenges for the company, but UG demonstrated resilience by adapting its operations and focusing on essential product categories.

Investment Considerations

Strengths:

  • Strong brand reputation and customer loyalty.
  • High-margin products with proprietary formulations.
  • Focus on niche markets with limited competition.
  • Financial stability and consistent dividend payments.

Risks:

  • Dependence on a limited number of products for revenue.
  • Exposure to regulatory and supply chain risks.
  • Competition from larger, well-funded companies.

Conclusion

United-Guardian, Inc. is a well-established company with a strong presence in the personal care, healthcare, and industrial markets. Its focus on innovation, quality, and customer relationships has enabled it to maintain a competitive edge. While the company faces certain risks, its strategic initiatives and commitment to sustainability position it for long-term growth. For investors, UG offers a compelling opportunity, particularly for those seeking exposure to niche markets with high growth potential.